1 yıllık getiri (CAGR)
39.47%
Johnson & Johnson Exchange (NYSE, USD)
JNJ
263.81
+9.83 (+3.81%)
HealthcareDrug Manufacturers - General
Loading...
3 yıllık getiri (CAGR)
19.69%
5 yıllık getiri (CAGR)
10.82%
10 yıllık getiri (CAGR)
8.54%
Adobe 2026 3. Çeyrek – Fiyatı piyasa algısı mı belirliyor?
Daha fazla okuPiyasa değeri
644.91B
Fiyat/Satış
6.59
Ent değeri
740.58B
Fiyat/Defter
7.59
DIV kazancı
2.00%
Büyüme yılları
58
DIV büyümesi
5.25%
FCF ödemesi
95.35%
Trailing P/E
30.66
PEG
4.79
İleri P/E
22.11
EPS büyümesi
14.90%
İş anlayişi
Temel Analizin Anlamı ve Metodolojisi (2025)
Daha fazla okuSegment Revenues ($M)
Loading...
Operations comments
In 21Q1 JNJ COVID-19 Vaccine authorized by U.S. FDA for emergency use
In 21Q1 JNJ Single-Shot COVID-19 Vaccine granted emergency use listing by the World Health Organization
In 21Q1 JNJ Single-Shot COVID-19 Vaccine granted conditional marketing authorization by European Commission
The company has not provided an official guidance for COVID-19 Vaccine revenues and margins for 2021
Geographic Revenues ($M)
Loading...